St Petersburg, FLNCT05865301Now EnrollingIRB Ready

Lymphoid Leukemia Clinical Trial in St Petersburg, FL

Access cutting-edge lymphoid leukemia treatment through this clinical trial at a research site in St Petersburg. Study-provided care at no cost to qualified participants.

Sponsored by Stanford University

Quick Self-Assessment

See if you qualify for this St Petersburg location

Preparing your pre-screening questions…

Expert Care in St Petersburg

Access lymphoid leukemia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related lymphoid leukemia treatment provided free

Apply for This St Petersburg Location

Check if you qualify for this lymphoid leukemia clinical trial in St Petersburg, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to St Petersburg

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit St Petersburg site if eligible
  4. 4Begin participation

About This Lymphoid Leukemia Study in St Petersburg

To use a consistent and standardized platform to retrospectively and prospectively study children and young adults with B cell malignancies receiving Immunotherapy, blinatumomab and/or inotuzumab ozogamicin.

Sponsor: Stanford University

Who Can Participate

Inclusion Criteria

Disease Status - B cell precursor acute lymphoblastic leukemia (ALL) or B cell lymphoma Who either:
Experienced refractory or relapsed disease, treated with standard chemotherapy, without immunotherapy treatment. OR
Previously undergone standard of care immunotherapy with FDA approved therapies, such as Kymriah™ (CTL019, tisagenlecleucel), blinatumomab or
Age: Greater than or equal to 0 year of age and less than or equal to 26 years of age. Inclusion Criteria (Arm B)
Disease Status - B cell precursor acute lymphoblastic leukemia (ALL) or B cell lymphoma
Age: Greater than or equal to 0 year of age and less than or equal to 26 years of age
Patients who are either:
Undergoing evaluation for leukapheresis for planned standard of care tisagenlecleucel therapy, or planned for therapy with blinatumomab or inotuzumab. (Patients who received prior tisagenlecleucel, blinatumomab or inotuzumab on an established clinical trial and are now scheduled for commercial CAR, blinatumomab or inotuzumab therapy are also eligible) Or
Experienced refractory or relapsed B cell precursor acute lymphoblastic leukemia (ALL) or B cell lymphoma
Ability to give informed consent. All subjects ≥ 18 years of age must be able to give informed consent or have legal authorized representative (LAR) (i.e. parent or guardian) to consent, if not in capacity to give consent independently. For subjects \<18 years old their LAR must give informed consent. Pediatric subjects will be included in age appropriate discussion and written assent will be obtained for those \> 7 years of age, when appropriate, according to institutional procedures.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in St Petersburg?

Yes, this clinical trial (NCT05865301) has an active research site in St Petersburg, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Lymphoid Leukemia Treatment Options in St Petersburg, FL

If you're searching for lymphoid leukemia treatment options in St Petersburg, FL, this clinical trial (NCT05865301) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our St Petersburg research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lymphoid leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all lymphoid leukemia clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in St Petersburg, FL

See all leukemia clinical trials recruiting in St Petersburg — not just this study.

Browse Leukemia Trials in St Petersburg →

Browse More Trials by Condition

Leukemia TrialsHeart Attack TrialsPulmonary Hypertension TrialsMyocardial Infarction TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in St Petersburg?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · St Petersburg, FL